Clinical Trial Update: Use of Anti-CD146 Autoantibodies for the Diagnosis of Pulmonary Diseases Secondary to Occupational Exposure to Silica [NA]

View source ↗

Summary

A clinical trial is evaluating anti-CD146 autoantibodies as a diagnostic tool for silica-related occupational pulmonary diseases, with recruitment not yet start…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumoconiosis
• Silicosis

Drugs mentioned

• Anti-CD146 autoantibody (anti-CD146 autoantibody)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Exposure Occupational, Pulmonary Diseases | NA | Status: NOT_YET_RECRUITING